what is euglycemic diabetic ketoacidosis
Release time :Nov-20,2024
Diabetic ketoacidosis (DKA) is a severe metabolic derangement typically linked to elevated blood glucose levels. However, there are instances where patients may develop a condition termed 'euglycemic diabetic ketoacidosis' (euglycemic DKA), characterized by normal blood glucose levels alongside ketone accumulation and acidosis.
The pathogenesis of euglycemic DKA is intricate and may involve factors such as insulin resistance, inadequate insulin secretion, and stress responses. In these cases, despite seemingly normal blood sugar levels, the body's inability to effectively utilize glucose due to insufficient insulin action leads to ketone production and accumulation. This phenomenon can affect individuals with type 1 diabetes and may also occur in those with type 2 diabetes, particularly when additional stressors are present, such as infections, surgeries, or severe illnesses.
Management of euglycemic DKA begins with identifying and addressing the underlying triggers. Timely insulin administration, correction of electrolyte imbalances, and monitoring to support organ functions are crucial interventions. Patients should vigilantly monitor their symptoms and seek immediate medical attention for any signs suggestive of DKA. Throughout treatment, it is imperative that patients adjust their insulin dosage under a physician's supervision and adhere to prescribed medical directives.